Routine sources ofdata on chickenpox morbidity and mortality in England and Wales were reviewed for 1967-85. Only two epidemics occurred, one in 1967 and one in 1980, both of which were immediately foliowed by two to three years oflow incidence. The age distribution of the disease appears to be changing, with more cases now being reported in children aged 0-4 years. The number of deaths in adults have, however, increased, particularly those deaths that are associated with pneumonia and immunosuppression. At present in England and Wales more deaths are attributed to chickenpox than to whooping cough and mumps.
Introduction
Chickenpox is one of the more readily communicable diseases of man. It first became prominent in Europe during the sixteenth century and was called chickenpox by Morton in 1694 and varicella by Vogel in 1765 (the name chickenpox being derived from cicer, a chickpea'). In Britain varicella infection is seemingly nearly universal by 40 years of age.2 It mainly causes a mild illness, especially in children, but may be severe, particularly in immunosuppressed people (the numbers of whom are increasing) and in adults. Vaccines have been developed in Japan and the United States and have been shown to be effective.3 '4 We review the recent epidemiology of chickenpox in England and Wales.
Methods and results
Routine sources of data were consulted to study trends in morbidity and mortality between 1967 and 1985. Four main sources were used. General practice morbidity data were obtained from the Weekly Returns Service of the Royal College of General Practitioners, which is based on a sample of 40 general practices which serve a population of about 220 000. 5 
Discussion
Information on the epidemiology of chickenpox was derived from four main sources which essentially cover four different types of population. Data from the Royal College of General Practitioners, which is community orientated, is the most valuable for monitoring the "normal distribution" of chickenpox, its seasonal pattern, and its age distribution, whereas laboratory data, based on both general practitioner and hospital cases, more typically reflect severe or atypical chickenpox. Nevertheless, the seasonal trends and secular patterns in laboratory data were similar to the college's reports. Since most cases of chickenpox are easily diagnosed clinically few cases are referred for laboratory investigation. On the other hand, hospital data were useful as a guide to the number of cases of severe chickenpox but were limited because no information on the severity or nature of the complication of the disease was available. The death entries gave the cause of death from chickenpox and associated complications.
675
Chickenpox is a notifiable disease in the United States and the second most commonly reported infection after-gonorrhoea.7 An estimated three million cases of chickenpox occur each year and at steady state conditions are said to approximate the yearly birth cohort.' Both the college's consultation data and a "serological age profile" (E Miller, personal communication, 1987) of cases were used to estimate the overall level of chickenpox cases each year in England and Wales. Using annual total live births as a denominator, the Royal College of General Practitioners' estimates indicated a range of about 118 000 to 430 000 cases a year, an average of 36% of cases to live births, whereas the serological profile suggested about 635 000 cases a year, more closely approximating the yearly birth rate.
The age distribution of the college's consultation rates was similar to that expected from the serological data except in those aged 45 or over. There was a higher estimate of cases from the consultation data than estimated from serological data, reflecting the greater severity of chickenpox infection in this age group.
The college's data show that since 1982 the highest consultation rates have changed from children aged 5-14 years to those aged 0-4 years (fig 3) , and most textbooks also claim that the peak age of infection is between 6 and 10 years. Our findings suggest that there has been a genuine change in the age distribution of chickenpox which may be accounted for by the fact that 1980 was an epidemic year so that children born in the succeeding years became the most susceptible group. A further possibility may be lower immunity in women, resulting in fewer babies with passive immunity. The higher rate of infection in the youngest children may also reflect changes in social organisation with more clustering of young children in nurseries and day care facilities.
Chickenpox is seriously undernotified in the United States.9 This view was supported by an American telephone survey which found that while most cases were reported by telephone to a physician the rate per physician visit was only 0 5 per case.'5 When the data from the Royal College of General Practitioners were used as a measure of overall morbidity in England and Wales, the shortfall in estimated total incidence with annual live births as a denominator suggested that underreporting of the disease was due to it being so mild in many children that parents recognised it and did not consult the family doctor, or perhaps sought a consultation for only the index case in a family and not for subsequent cases.
Our results confirm that chickenpox commonly affects children, and serological data support this.2 The change in the age distribution of clinical chickenpox since 1982 has probably accentuated the difference in mortality in age groups. Both the college's returns and hospital discharge data show that the highest incidence of clinical infection from chickenpox is now in the age group 0-4 years, who have, however, a low case fatality rate compared with adults. Moreover, the proportion of deaths in the age group 0-4 fell steadily from 23% of all deaths between 1967 and 1981 to 13-5% between 1982 and 1985. A similar fall occurred in the 5-14 year age group, with 17-5% of all deaths in 1982-5 compared with 26% in 1967-81. Reports of chickenpox in those aged 15-44 between 1982 and 1985 constituted 5% of the college's returns and 35% of death certifications, while those in the age group 45 and over accounted for 0 5% of the college's returns and 39% of death certifications. Deaths in adults, which have increased relative to the total number of deaths each year, appear to be increasingly associated with pneumonia and immunosuppression.
Decisions whether to vaccinate more extensively against chickenpox are difficult to make without knowing the effect that existing vaccines will have on herpes zoster. In view of the relatively high case mortality rates for chickenpox in adults compared with children the length of time for which the vaccine will afford protection is clearly also important. The number of certified deaths from chickenpox exceeds that from mumps in Britain, and complications seem to be more serious than with mumps, an infection against which routine vaccination will shortly be introduced. Live varicella virus vaccines have been successfully used for some years,34 and a combined vaccine with measles, mumps, and rubella has been on trial. A clinical study of the complication rate for chickenpox in all ages and cost benefit studies needs to be carried out in Britain before the universal use of varicella vaccine can be seriously considered. This does not preclude more extensive selective use of the vaccine in those at special risk, such as immunosuppressed patients.
Introduction
The oral glucose tolerance test is a well established method of identifying patients with abnormal carbohydrate metabolism. Though the influence of pregnancy on glucose tolerance has often been investigated, there are discrepancies among the reports: the glucose tolerance test has been reported to be unchanged' or impaired.23 A possible explanation of these opposing views may be variations in the carrying out of the test and in the interpretation of the data.
Methodological changes have taken place in the measurement of plasma glucose concentrations during the last 20 years. Earlier studies used the alkaline ferricyanide method, but this has been superseded by more specific enzyme assays that give results about 10% lower, are more sensitive, and specify the normal range with better precision.
Criteria As a consequence of these opposing views a standardised glucose load of 75 g was recommended by an international working party in 1979,7 and this has been accepted by the expert committee on diabetes of the World Health Organisation.8 There have, nevertheless, been no studies to determine the reference values for the 75 g oral glucose tolerance test in pregnancy, and the present study was designed to remedy this.
